Table 3.
Antibiotic resistance profiles of Staphylococcus species isolated from dogs with bacterial conjunctivitis
| Antibiotic | Numbers and % of resistant and susceptible bacteria | Total % of resistance | |||||
|---|---|---|---|---|---|---|---|
| S. epidermidis (n = 45) | S. aureus (n = 25) | S. pseudintermedius (n = 10) | |||||
| R | S | R | S | R | S | ||
| Amoxicillin AML25 | 26.6 | 73.4 | 76 | 24 | 20 | 80 | 41.5 |
| Amoxicillin/clavulanic acid AMC30 | 6.6 | 93.4 | 24 | 76 | 0 | 100 | 11.25 |
| Ampicillin AMP10 | 8.9 | 91.1 | 100 | 0 | 20 | 80 | 38.75 |
| Amikacin AN 30 | 71.1 | 28.9 | 60 | 40 | 40 | 60 | 63.75 |
| Enrofloxacin ENR5 | 22.2 | 77.8 | 8 | 92 | 30 | 70 | 18.75 |
| Lincomycin/spectinomycin LS109 | 0 | 100 | 0 | 100 | 100 | 0 | 12.5 |
| Sulfamethoxazole/trimethoprim SXT25 | 80 | 20 | 72 | 28 | 70 | 30 | 76.25 |
| Polymyxin PB 300 | 0 | 100 | 0 | 100 | 0 | 100 | 0 |
| Erythromycin E 15 | 100 | 0 | 0 | 0 | 100 | 0 | 100 |
| Gentamicin CN 10 | 15.5 | 84.5 | 12 | 88 | 100 | 0 | 25 |
| Tetracycline TE | 97.7 | 2.3 | 100 | 0 | 100 | 0 | 100 |
| Clindamycin DA 2 | 6.66 | 93.34 | 52 | 48 | 0 | 10 | 20 |
| Oxacillin OXA 1 | 10 | 0 | 100 | 0 | 100 | 0 | 100 |
| Vancomycin VA 30 | 0 | 100 | 12 | 88 | 0 | 10 | 3.75 |
| Tobramycin TOB 10 | 55.5 | 44.5 | 36 | 64 | 70 | 30 | 51.25 |
| Kanamycin K 30 | 66.7 | 33.3 | 100 | 0 | 40 | 60 | 73.75 |
| Ciprofloxacin CIP 5 | 0 | 100 | 4 | 96 | 0 | 100 | 1.25 |
| Methicillin MEL 10 | 2.2 | 97.8 | 12 | 88 | 0 | 100 | 32.5 |
Legend: Numbers in parentheses indicate percentages of strains